Cambridge, MA, United States of America

Brie Skinner

This inventor holds 1 USPTO granted patent. Top assignee: Ares Capital Corporation, as Agent. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brie Skinner. Retrieved from https://idiyas.com/inventor/brie-skinner-ptcyld7l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brie Skinner: Innovator in Lipid Nanoparticle Technology

Introduction

Brie Skinner is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of lipid nanoparticles, which are crucial in various biomedical applications. Her innovative work has led to the development of methods that enhance the preparation of these nanoparticles.

Latest Patents

Brie Skinner holds 1 patent for her invention titled "Methods of Preparing Lipid Nanoparticles." This patent showcases her expertise and dedication to advancing technology in her field.

Career Highlights

Brie currently works at Ares Capital Corporation as an Agent. Her role involves leveraging her knowledge and skills to contribute to the company's innovative projects. Her career reflects a commitment to excellence and a passion for scientific advancement.

Collaborations

Brie collaborates with talented individuals such as Mike Smith and Allen Horhota. These partnerships enhance her work and contribute to the success of her projects.

Conclusion

Brie Skinner is a remarkable inventor whose work in lipid nanoparticles is paving the way for future innovations. Her contributions to the field are invaluable and demonstrate her dedication to scientific progress.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…